Page last updated: 2024-08-21

alpha-aminopyridine and Milk-Alkali Syndrome

alpha-aminopyridine has been researched along with Milk-Alkali Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abedini, A; Auguste, A; Bertos, N; Cencic, R; Chen, H; Clarke, BA; de Rink, I; Dostie, J; Firlit, M; Foulkes, WD; Gotlieb, WH; Guiot, MC; Hass, R; Huang, S; Jelinic, P; Johnson, RM; Judkins, AR; Kerkhoven, RM; Kong, T; Leary, A; Levine, DA; Macdonald, E; Martinez, D; Meehan, B; Morin, G; Papadakis, AI; Park, M; Patibandla, J; Pelletier, J; Rak, J; Vanderhyden, B; Venneti, S; Wang, XQD; Witcher, M; Witkowski, L; Xue, Y1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Milk-Alkali Syndrome

ArticleYear
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.
    Nature communications, 2019, 02-04, Volume: 10, Issue:1

    Topics: Aminopyridines; Animals; Benzimidazoles; Carcinoma, Small Cell; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; Cyclin D1; DNA Helicases; Female; Humans; Hypercalcemia; Mice; Mice, SCID; Nuclear Proteins; Ovarian Neoplasms; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; RNA, Small Interfering; Transcription Factors

2019